CN110023513A - 预测乳腺癌患者预后的方法 - Google Patents
预测乳腺癌患者预后的方法 Download PDFInfo
- Publication number
- CN110023513A CN110023513A CN201780073330.5A CN201780073330A CN110023513A CN 110023513 A CN110023513 A CN 110023513A CN 201780073330 A CN201780073330 A CN 201780073330A CN 110023513 A CN110023513 A CN 110023513A
- Authority
- CN
- China
- Prior art keywords
- breast cancer
- prognosis
- genes
- gene
- predicting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310354509.5A CN116356030A (zh) | 2016-11-25 | 2017-11-27 | 预测乳腺癌患者预后的方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160158466A KR101896545B1 (ko) | 2016-11-25 | 2016-11-25 | 유방암 환자의 예후 예측 방법 |
| KR10-2016-0158466 | 2016-11-25 | ||
| PCT/KR2017/013602 WO2018097678A1 (ko) | 2016-11-25 | 2017-11-27 | 유방암 환자의 예후 예측 방법 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310354509.5A Division CN116356030A (zh) | 2016-11-25 | 2017-11-27 | 预测乳腺癌患者预后的方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110023513A true CN110023513A (zh) | 2019-07-16 |
Family
ID=62195317
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780073330.5A Pending CN110023513A (zh) | 2016-11-25 | 2017-11-27 | 预测乳腺癌患者预后的方法 |
| CN202310354509.5A Pending CN116356030A (zh) | 2016-11-25 | 2017-11-27 | 预测乳腺癌患者预后的方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310354509.5A Pending CN116356030A (zh) | 2016-11-25 | 2017-11-27 | 预测乳腺癌患者预后的方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11220716B2 (https=) |
| EP (1) | EP3524689B1 (https=) |
| JP (1) | JP7228896B2 (https=) |
| KR (1) | KR101896545B1 (https=) |
| CN (2) | CN110023513A (https=) |
| ES (1) | ES2962775T3 (https=) |
| WO (1) | WO2018097678A1 (https=) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110938698A (zh) * | 2019-12-27 | 2020-03-31 | 南京医科大学 | Sox9在预测三阴性乳腺癌对CDK7抑制剂THZ1敏感性中的应用 |
| CN113355419A (zh) * | 2021-06-28 | 2021-09-07 | 广州中医药大学(广州中医药研究院) | 一种乳腺癌预后风险预测标志组合物及应用 |
| CN113862363A (zh) * | 2021-10-27 | 2021-12-31 | 中山大学附属第一医院 | 免疫相关基因在乳腺癌预后的试剂盒和系统中的应用 |
| CN117589991A (zh) * | 2024-01-18 | 2024-02-23 | 天津云检医学检验所有限公司 | 一种用于乳腺癌患者her2表达状态鉴定的生物标志物、模型、试剂盒及用途 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| EP3856933A1 (en) * | 2018-09-27 | 2021-08-04 | BioNTech Diagnostics GmbH | Predictive and prognostic methods in breast cancer |
| US12019674B2 (en) | 2019-05-29 | 2024-06-25 | New York University | System and method for tumor characterization |
| EP3907301A1 (en) * | 2020-05-08 | 2021-11-10 | Istituto Europeo di Oncologia S.r.l. | Methods and kits for determining the risk of breast cancer recurrence |
| KR102422610B1 (ko) * | 2020-05-12 | 2022-07-18 | 서울대학교 산학협력단 | 초기 유방암 환자의 예후 예측 방법 |
| KR102789795B1 (ko) * | 2021-09-23 | 2025-04-01 | 사회복지법인 삼성생명공익재단 | 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템 |
| CN113981081A (zh) * | 2021-10-22 | 2022-01-28 | 中山大学 | 一种基于rna编辑水平的乳腺癌分子标志物及诊断模型 |
| KR102778416B1 (ko) | 2022-02-07 | 2025-03-07 | 사회복지법인 삼성생명공익재단 | 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템 |
| KR102849648B1 (ko) | 2022-02-07 | 2025-08-21 | 사회복지법인 삼성생명공익재단 | 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템 |
| KR20230119541A (ko) | 2022-02-07 | 2023-08-16 | 사회복지법인 삼성생명공익재단 | 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템 |
| KR20230119540A (ko) | 2022-02-07 | 2023-08-16 | 사회복지법인 삼성생명공익재단 | 유방 재건술의 예후를 예측하기 위한 정보의 제공 방법 및 시스템 |
| WO2025110726A1 (ko) * | 2023-11-20 | 2025-05-30 | 주식회사 디시젠 | 콕스 회귀 분석 알고리즘을 적용한 암 위험도에 대한 정보를 제공하는 방법 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160102359A1 (en) * | 2013-04-18 | 2016-04-14 | Gencurix Inc. | Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2338843B1 (es) * | 2008-07-02 | 2011-01-24 | Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas | Huella genomica de cancer de mama. |
| EP2845911B1 (en) * | 2010-03-31 | 2016-05-18 | Sividon Diagnostics GmbH | Method for breast cancer recurrence prediction under endocrine treatment |
| KR101287600B1 (ko) * | 2011-01-04 | 2013-07-18 | 주식회사 젠큐릭스 | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 |
| KR101725985B1 (ko) * | 2013-01-28 | 2017-04-13 | 주식회사 젠큐릭스 | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 |
| US10655187B2 (en) * | 2013-04-18 | 2020-05-19 | Gencurix Inc. | Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof |
| KR101748867B1 (ko) * | 2013-04-19 | 2017-06-20 | 주식회사 젠큐릭스 | 조기 유방암 예후 예측 진단용 자동화 시스템 |
-
2016
- 2016-11-25 KR KR1020160158466A patent/KR101896545B1/ko active Active
-
2017
- 2017-11-27 CN CN201780073330.5A patent/CN110023513A/zh active Pending
- 2017-11-27 WO PCT/KR2017/013602 patent/WO2018097678A1/ko not_active Ceased
- 2017-11-27 JP JP2019527493A patent/JP7228896B2/ja active Active
- 2017-11-27 ES ES17874456T patent/ES2962775T3/es active Active
- 2017-11-27 CN CN202310354509.5A patent/CN116356030A/zh active Pending
- 2017-11-27 EP EP17874456.1A patent/EP3524689B1/en active Active
-
2018
- 2018-03-28 US US15/938,633 patent/US11220716B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160102359A1 (en) * | 2013-04-18 | 2016-04-14 | Gencurix Inc. | Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof |
Non-Patent Citations (2)
| Title |
|---|
| MARIE KLINTMAN: "Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease", 《CLIN CANCER RES》 * |
| MI JEONG KWON: "Identification of Novel Reference Genes UsingMultiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis", 《PLOS ONE》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110938698A (zh) * | 2019-12-27 | 2020-03-31 | 南京医科大学 | Sox9在预测三阴性乳腺癌对CDK7抑制剂THZ1敏感性中的应用 |
| CN113355419A (zh) * | 2021-06-28 | 2021-09-07 | 广州中医药大学(广州中医药研究院) | 一种乳腺癌预后风险预测标志组合物及应用 |
| CN113355419B (zh) * | 2021-06-28 | 2022-02-18 | 广州中医药大学(广州中医药研究院) | 一种乳腺癌预后风险预测标志组合物及应用 |
| CN113862363A (zh) * | 2021-10-27 | 2021-12-31 | 中山大学附属第一医院 | 免疫相关基因在乳腺癌预后的试剂盒和系统中的应用 |
| CN117589991A (zh) * | 2024-01-18 | 2024-02-23 | 天津云检医学检验所有限公司 | 一种用于乳腺癌患者her2表达状态鉴定的生物标志物、模型、试剂盒及用途 |
| CN117589991B (zh) * | 2024-01-18 | 2024-03-29 | 天津云检医学检验所有限公司 | 一种用于乳腺癌患者her2表达状态鉴定的生物标志物、模型、试剂盒及用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3524689C0 (en) | 2023-09-06 |
| JP2020500515A (ja) | 2020-01-16 |
| EP3524689B1 (en) | 2023-09-06 |
| EP3524689A1 (en) | 2019-08-14 |
| WO2018097678A1 (ko) | 2018-05-31 |
| EP3524689A4 (en) | 2020-05-27 |
| KR20180059192A (ko) | 2018-06-04 |
| ES2962775T3 (es) | 2024-03-21 |
| US11220716B2 (en) | 2022-01-11 |
| JP7228896B2 (ja) | 2023-02-27 |
| CN116356030A (zh) | 2023-06-30 |
| US20180216199A1 (en) | 2018-08-02 |
| KR101896545B1 (ko) | 2018-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7228896B2 (ja) | 乳がん患者の予後の予測方法 | |
| JP7042784B2 (ja) | 遺伝子発現を用いた前立腺癌の予後を定量化する方法 | |
| JP7430415B2 (ja) | 乳がん患者の化学治療の有用性を予測する方法 | |
| AU2020204502B2 (en) | Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer | |
| US20140154681A1 (en) | Methods to Predict Breast Cancer Outcome | |
| CN103384829A (zh) | 预测大肠直肠癌复发的生物标记 | |
| US11840733B2 (en) | Method for predicting prognosis of breast cancer patient | |
| CN115216543A (zh) | 核酸探针或引子在制备用于评估乳癌复发与转移风险方法的试剂盒的应用 | |
| KR20140121523A (ko) | 위암에 대한 예후 예측 시스템 | |
| NZ752676B2 (en) | Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer | |
| NZ711680B2 (en) | Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190716 |
|
| RJ01 | Rejection of invention patent application after publication |